169 related articles for article (PubMed ID: 12396745)
1. Management of rosiglitazone-induced edema: two case reports and a review of the literature.
Wang F; Aleksunes LM; Reagan LA; Vergara CM
Diabetes Technol Ther; 2002; 4(4):505-14. PubMed ID: 12396745
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
Mudaliar S; Chang AR; Henry RR
Endocr Pract; 2003; 9(5):406-16. PubMed ID: 14583425
[TBL] [Abstract][Full Text] [Related]
3. Considerations for management of fluid dynamic issues associated with thiazolidinediones.
Hollenberg NK
Am J Med; 2003 Dec; 115 Suppl 8A():111S-115S. PubMed ID: 14678876
[TBL] [Abstract][Full Text] [Related]
4. Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.
Reyes-Morales H; Mino-León D; Doubova SV; Flores-Hernández S
Int J Clin Pharmacol Ther; 2012 Jan; 50(1):1-9. PubMed ID: 22192639
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxicity with thiazolidinediones: is it a class effect?
Scheen AJ
Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
[TBL] [Abstract][Full Text] [Related]
6. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
King AB
Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952
[No Abstract] [Full Text] [Related]
7. A review of rosiglitazone in type 2 diabetes mellitus.
Werner AL; Travaglini MT
Pharmacotherapy; 2001 Sep; 21(9):1082-99. PubMed ID: 11560198
[TBL] [Abstract][Full Text] [Related]
8. Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
Buch HN; Baskar V; Barton DM; Kamalakannan D; Akarca C; Singh BM
Diabet Med; 2002 Jul; 19(7):572-4. PubMed ID: 12099960
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.
Malinowski JM; Bolesta S
Clin Ther; 2000 Oct; 22(10):1151-68; discussion 1149-50. PubMed ID: 11110228
[TBL] [Abstract][Full Text] [Related]
10. Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
Tang WH; Francis GS; Hoogwerf BJ; Young JB
J Am Coll Cardiol; 2003 Apr; 41(8):1394-8. PubMed ID: 12706937
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone for type 2 diabetes mellitus.
Med Lett Drugs Ther; 1999 Aug; 41(1059):71-3. PubMed ID: 10603986
[No Abstract] [Full Text] [Related]
12. Thiazolidinedione-induced edema.
Niemeyer NV; Janney LM
Pharmacotherapy; 2002 Jul; 22(7):924-9. PubMed ID: 12126225
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Kermani A; Garg A
Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone-induced anasarca without heart failure: capillary leakage?
Dagdelen S; Kurt M; Aydin K; Bayraktar M
Hormones (Athens); 2008; 7(2):180-3. PubMed ID: 18477557
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
Lebovitz HE; Kreider M; Freed MI
Diabetes Care; 2002 May; 25(5):815-21. PubMed ID: 11978674
[TBL] [Abstract][Full Text] [Related]
16. Unilateral edema due to a thiazolidinedione.
Bell DS
Diabetes Care; 2003 Sep; 26(9):2700. PubMed ID: 12941750
[No Abstract] [Full Text] [Related]
17. Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels.
Olansky L; Marchetti A; Lau H
Clin Ther; 2003; 25 Suppl B():B64-80. PubMed ID: 14553867
[TBL] [Abstract][Full Text] [Related]
18. Significant weight gain with rezulin therapy.
Gorson DM
Arch Intern Med; 1999 Jan; 159(1):99. PubMed ID: 9892338
[No Abstract] [Full Text] [Related]
19. Differentiating members of the thiazolidinedione class: a focus on safety.
Lebovitz HE
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S23-9. PubMed ID: 11921435
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinedione-induced edema in patients with heart failure.
Stroup JS
Am J Health Syst Pharm; 2007 Dec; 64(23):2426-30; author reply 2430. PubMed ID: 18029947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
